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Reliable separation and isolation of target single cells from bodily ﬂuids with high
purity is of great signiﬁcance for an accurate and quantitative understanding of the
cellular heterogeneity. Here, we describe a fully integrated single-blood-cell analysis
platform capable of size-selective cell separation from a population containing a
wide distribution of sizes such as diluted blood sample and highly efﬁcient entrap-
ment of single monocytes. The spiked single U937 cells (human monocyte cell
line) are separated in sequence by two different-sized microﬁlters for removing
large cell clumps, white blood cells, and red blood cells and then discriminated by
dielectrophoretic force and isolated individually by downstream single-cell trapping
arrays. When 2% hematocrit blood cells with a ﬁnal ratio of 1:1000 U937 cells were
introduced under the ﬂow rate of 0.2 ml/h, 400 U937 cells were trapped sequentially
and deterministically within 40 s with single-cell occupancy of up to 85%. As a
proof-of-concept, we also demonstrated single monocyte isolation from diluted
blood using the integrated microﬂuidic device. This size-selective, label-free, and
live-cell enrichment microﬂuidic single blood-cell isolation platform for the process-
ing of cancer and blood cells has a myriad of applications in areas such as single-
cell genetic analysis, stem cell biology, point-of-care diagnostics, and cancer
diagnostics. Published by AIP Publishing. https://doi.org/10.1063/1.5049149
INTRODUCTION
Understanding intra-sample genomic heterogeneity may hold valuable clues about detailed
insight into the origins of human disease pathways and gene expression kinetics that is of great
interest in clinical and biomedical communities.1,2 For example, measurement of gene expression
by counting single biomolecules from clinical bio-samples such as human tumor tissues3,4 and
stem cells5 contributes to the treatment and prevention of major ailments. Additionally, abnormal
gene expression of distinct mRNAs can be taken as a good indicator of cellular irregularity. Many
analytical cell-based assays, including reverse-transcription quantitative PCR (RT-qPCR), western
blot, immunocytochemistry, and enzyme-linked immunosorbent assay (ELISA), measure only the
average response from cell population. But the averaging in these measurements masks the intrinsic
intra-sample heterogeneity at the single-cell level within cell communities.6,7 This intra-sample het-
erogeneity provides valuable clues for designing therapeutic administrations and designating treat-
ments for different conditions according to the variability between the responses of patients, which
could not be inferred from traditional bulk cell analyses.8–10 Therefore, accurate single-cell pheno-
typing technologies including isolating, monitoring, and extracting of biomolecules are required to
explore the intra-sample heterogeneity caused by stochastic ﬂuctuations in external responses.11,12
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For an accurate and quantitative understanding of the cellular heterogeneity, it is important to
separate and isolate targeted single-cell populations from the unwanted and contaminated cells and
then collect the isolated cells with high purity. Isolation of single cells using microﬂuidics is becom-
ing an essential tool for the selection and identiﬁcation of target cells within the array of available
biological ﬂuids toward clinical practicality.13 Speciﬁcally, the capture and analysis of single mono-
cytes could provide information about the immune system such as phagocytizing and degrading
foreign microorganisms in the body.14 As monocytes in blood are rare (5% in whole blood), isolation
of target monocytes of interest from the background of erythrocytes and other leukocytes is therefore
important to proﬁle expression levels in individual monocytes.15 Powerful approaches for the separa-
tion of monocytes from human blood have been reported;16,17 however, many existing devices still
needed a time-consuming labeling procedure and have yielded low sample purities, causing chal-
lenges in downstream analysis. The inherent heterogeneity of extremely low frequency monocytes
dictates the need for an effective analysis method at the single-cell level but approaches for label-free
isolation of single monocytes using microﬂuidic devices have not been fully developed.
Microwell arrays, miniaturized replicas of 96-well plates, allow cells to be localized and monitored
at the single-cell level.18–21 Several well-established single-cell isolation technologies based on dielec-
trophoresis, magnetism, and acoustic and mechanical valves have been utilized to isolate single cells in
the miniaturized trapping arrays with high efﬁciency and accuracy. However, these techniques require
external sources and complicated operations and therefore have signiﬁcant hurdles such as the mainte-
nance of cell viability due to an excessive localized electric ﬁeld gradient, integration with other micro-
ﬂuidic components, and device parallelization for larger-scale sample processing. Hydrodynamic
passive trapping with careful design of microwells that use gravity or ﬂuid ﬂow enables up to 70%
single-cell capture without compromising cell viability. However, this approach has not been applied to
target cells from a mixture of different-sized cells/particles because the microwell arrays were designed
to isolate microparticles of a speciﬁc size.20 There are a number of methods that have been adapted to
isolate single cells microﬂuidically in a hydrodynamic manner, but the microﬂuidic separation module
is usually completely separated from the microwell arrays. Kim et al. have reported a cell bandpass ﬁlter
integrated with a microﬂuidic single-cell array to separate and isolate single cells with polydisperse dis-
tributions.22 They used pinched ﬂow fractionation to continuously separate cells with different sizes by
utilizing multiple bypass microchannels; however, these bypass channels resulted in complicated micro-
channel networks that limited the number of cell traps (<20). Also, Kim et al. developed a
trapping-and-sorting microﬂuidic device that can allocate particles to different trap zones by size.23
They employed additional side channels to isolate and decouple ﬂuid ﬂow between each trap zone. This
device, however, has limitations in the separation of high-concentrated samples and is low throughput.
In this paper, we aim to develop a fully-integrated single-blood-cell analysis platform that is
capable of size-selective cell separation from diluted blood samples and highly efﬁcient entrapment
of single cells in a single device. Two different-sized microﬁlters are designed in sequence for
removing large cell clumps, white blood cells (WBCs), and red blood cells (RBCs) so that continu-
ous separation of a targeted cells population with an intermediate size is achieved. Most cancer cell
lines such as MCF-7, SK-BR-3 (human breast), HeLa (human carcinoma), and K562 (leukemia)
can also be retained in the ﬁlter array due to their intermediate sizes. We spiked U937 cells (human
monocyte cell line) as a model cell line to mimic macrophage behavior. The separated targeted
U937 cells can then be discriminated by dielectrophoretic force and isolated individually by down-
stream trapping arrays.24 This straightforward approach enables efﬁcient separation and recovery of
medium-sized cells and facilitates the individual trapping of target cells without moving parts or
external forces. As a proof-of-concept, we also demonstrated the isolation of 200 single monocytes
using the microﬁlters and dielectrophoretic (DEP) separation from diluted blood.
WORKING PRINCIPLES
Microﬂuidic device design
Figure 1(a) shows a conceptual representation of the presented device. The prototype is com-
posed of four different microﬂuidic modules—a hydrodynamic microﬁlter, a sheathless cell
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focuser, a DEP separator, and a single-cell microwell array—connected sequentially from the inlet.
The ﬁrst microﬁlter F1 is designed for large cell and clumps trapping (target cell diameter >18 μm),
and the second microﬁlter F2 is for medium-size cell separation and recovery (target cell diameter
>10 μm) [Fig. 1(b)]. The basic mechanism of cell trapping and size-based sorting is similar to that
of the sieve. Cells smaller than the pore size pass through the ﬁlter (e.g., RBCs and smaller WBCs
except monocytes), whereas cells larger than the pore size such as U937 cells are trapped geometri-
cally. When a U937 cell-spiked blood sample is introduced to the inlet I1, the U937 cell aggregates
are ﬁltered through F1 while RBCs, smaller WBCs, and U937 cells are transported to F2 along the
main channel. The height of the F2 microﬁlter and main channel is set to 19 μm. Then, to collect
captured single U937 cells, we reverse the ﬂow by adding PBS at the outlet O1 after the removal
of RBCs and smaller WBCs at O1 using a syringe pump with the withdrawal mode. Consequently,
single U937 cells ranging from 10 to 18 μm are completely separated from RBCs and smaller
WBCs and transferred to the downstream isolation area. The overall design is presented in
Fig. S1(a) in the supplementary material.
The cell focusing channel comprises a series of ridges having the slanted geometry (40 μm in
height) that directs cells to either side of the microchannel tightly based on hydrophoresis without
the assistance of sheath ﬂuid. Hydrophoresis handles particle displacement laterally by generating
helical streamlines at the slanted grooves in microchannels.25 The local anisotropy of the grooves
constructs rotational ﬂows that are transverse to the main ﬂow direction. If the groove gap satisﬁes
the design criteria for particle ordering by hydrophoresis,26,27 the cells can be displaced from the
original streamline toward the channel wall by steric interactions. To ensure hydrophoretic ordering
of the U937 cells ranged from 10 to 18 μm in diameter, we set hg = 18 μm and ht = 22 μm. While
the U937 cells were unfocused in the non-grooved channel, most of the U937 cells were success-
fully focused into the side of the microchannel along the slanted obstacle arrays, achieving a
narrow focusing stream [Fig. 1(b)]. The tightly focused U937 cells were transported to the DEP
separation zone, where viable U937 cells were separated from non-viable ones by dielectrophoresis
under the non-uniform electric ﬁeld. The chevron-shaped DEP electrodes consist of 25 nm thick
chromium, which act as an adhesion layer for the 250 nm thick conductive gold electrodes. The
viable U937 cells were deﬂected toward the microchannel center by positive DEP and transported
FIG. 1. A microﬂuidic platform for the integrated microﬂuidic platform for size-selective single-cell trapping. (a) Schematic
illustration of the microﬂuidic platform comprising the hydrodynamic ﬁlters, obstacle array, DEP electrode, and the array of
single-cell traps. (b) Schematic of the process of size-selective single-cell trapping. Two different-sized microﬁlters are
designed in sequence for removing large cell clumps (target cell diameter >18 μm), smaller WBCs and RBCs (target cell
diameter <10 μm) so that continuous separation of a targeted U937 cells and monocytes population with an intermediate
size is achieved. The separated targeted cancer cells can then be discriminated by dielectrophoretic force and isolated indi-
vidually by downstream trapping arrays.
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to the single-cell microwell array, whereas the non-viable U937 cells maintained their trajectory
and were removed via outlet O2. Finally, the separated viable U937 cells were delivered to the
single-cell trapping zone and captured passively and sequentially in the 18 × 18 × 16 μm3 sized
microwells.
In order to trap single cells passively, we placed an array of densely packed traps, previously
reported for high-density cell trapping.24,28,33 The continuous single-cell trapping process is based
on the combination of perpendicular deformation and horizontal delivery ﬂow. The microﬂuidic
trapping region involves highly packed 400 single-cell traps which enables observation and identi-
ﬁcation of every single U937 cell ﬂowing through the microﬂuidic channel. Each trapping unit has
a smaller height of the trap (hT) than the height of the main delivery channel (H), resulting in a
gap area (hG =H− hT). Therefore, DEP-separated viable U937 cells follow the bulk continuous
ﬂuid and are pushed into the traps by the vertical ﬂow through the gap area.
DEP electrode design
DEP is a phenomenon in which a force is exerted on a dielectric particle when it is subjected
to a non-uniform electric ﬁeld. More speciﬁcally, this force is induced by the interaction of the par-
ticle’s dipole and the spatial gradient of the surround electric ﬁeld. The magnitude and direction of
the force is strongly dependent on the particle’s physical and dielectric properties, as well as the
characteristics of the electric ﬁeld. For a uniform spherical particle, the time-averaged DEP force
can be expressed as follows:
FDEP ¼ 2πεmR3Re(β)rE2 and β ¼ (εcell  εm)=(εcell þ 2εm),
where εm is the permittivity of the medium, R is the radius of the cell, E is the strength of the
applied electric ﬁeld, β is the Clausius–Mossotti (CM) factor, and ∇ is the gradient operator. The
complex permittivity (ε*) is a function of frequency (ω), which indicates that the value for the
term inside the parenthesis in the equation is a function of the applied electrical ﬁeld frequency. It
deﬁnes both the magnitude and directions of the force with respect to the frequency of the applied
electric ﬁeld, and the permittivity and conductivity of the particle and its surrounding medium. For
a single shell model, in case of Re(β) < 0 or Re(β) > 0, cells will be migrated away (negative DEP)
or toward (positive DEP) the direction of increasing electric ﬁeld. Furthermore, the direction of
DEP mobility at a particular frequency is also sensitive to the cell size/shape and the protein
density on the cell membrane and cell wall, which vary widely for different species, and is distinct
for live/dead and diseased/healthy cells. As a result, this phenomenon is being used in many
research applications as a label-free method to sort and manipulate microparticles, nanoparticles,
and biological cells.29,30
The main key to the separation of viable cells is a DEP operation regime, in which Re(β) on
the two cell populations are different. Based on a single shell model, viable cells exposed to
several kHz with a larger Re(β) experience stronger DEP force resulting in a larger lateral deﬂec-
tion than those with a smaller Re(β) (non-viable cells) because of the different polarization of
impaired dead cell membrane under the applied electric ﬁeld.31 Song et al. reported an oblique
interdigitated electrodes array that is capable of continuously separating human mesenchymal stem
cells and their differentiation progenies when controlled by an AC electric ﬁeld with alternating on/
off control.32 By modifying the electrode conﬁguration into a V-shaped interdigitated electrode
array, this subsystem was then incorporated into our single-cell analysis platform to separate live
and dead cells continuously. The COMSOL electrostatic simulation in Figure S1(b) in the supple-
mentary material simulates the electric ﬁeld converging on the surface of the electrodes when an
electric potential is applied between them; hence, at frequencies where the CM factor is positive,
the cells will be pulled laterally along the electrode due to DEP. Also, there is a hydrodynamic
force induced by ﬂuid ﬂow pushing the cell along the microchannel. Finally, the deﬂected viable
cells based on the combined forces acting on them can be collected at the center outlet and the non-
viable cells at the side outlet.
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MATERIALS AND METHODS
Cell culture
U937 (monoblast cell line, average diameter ∼14 μm) cells were purchased from American
Type Culture Collection and cultured in RPMI1640 medium (Gibco) supplemented with 10% fetal
bovine serum (FBS; Gibco). Cells were passaged every 2–3 days following standard protocols and
cultured in a humidiﬁed incubator at 37 °C with 5% CO2.
Blood samples
The human blood samples were collected, with informed consent, from healthy donors in UCI
General Clinical Research Center with Institutional Review Board approval. Vacutainer tubes (BD
Bioscience) containing EDTA as an anticoagulant were used for collection.
Device fabrication
We used standard multi-layer microfabrication techniques to fabricate the silicon master of
microﬂuidic channels and to produce the microﬂuidic device. A 3-in. silicon wafer is ﬁrst patterned
using standard multi-layer photolithography and the patterned silicon wafer was treated with
trichloro(1H,1H,2H,2H-perﬂuorooctyl)silane for 1 h to avoid the adhesion of poly-dimethylsiloxane
(PDMS). Then, PDMS prepolymer is mixed in a 10:1 (wt/wt) ratio with a curing agent and poured
onto the silanized wafer. After baking at 65 °C for 3 h, the cured PDMS is peeled from the mold,
and access holes (1.5 mm) for ﬂuidic inlet and outlets are punched by using a Uni-Core puncher
(Ted Pella Inc., Redding, CA, USA). The PDMS device is irreversibly bond to the glass slide upon
oxygen plasma treatment.
RESULTS AND DISCUSSION
Separation of single live U937 cells from diluted blood samples
The separation of U937 cells from diluted blood is performed using a matrix of micrometer-
sized PDMS structures consisting of 10 rows and 250 columns. The pore size of the ﬁlter is kept
constant along each row from 8 to 12 μm. The ability to separate U937 cells from diluted blood
was initially tested by doping U937 cells into diluted blood (2% hematocrit). We conducted experi-
ments at a doping ratio of one U937 cell to 1000 WBCs to characterize the parameters relevant to
the isolation of single U937 cells. When diluted blood is introduced into the bottom-left corner of
the matrix, ﬂuid ﬂow transports cells in a diagonal path from the bottom-left to the top-right of the
matrix. While RBCs and WBCs ﬂowed to the top of the matrix and exited through the outlet
channel because of their smaller diameter than the ﬁlter gap, the U937 cells are captured at the
hydrodynamic ﬁlter due to their size. The capture rate of U937 cells can be tuned by adjusting the
ﬁlter gap and the ﬂow rates applied at the inlet. We examined the capture rate of U937 cells with
diluted whole blood samples of 2% hematocrit to investigate the effect of gap distance on U937
cell capture in the matrix [Fig. 2(a)]. The results explained that the U937 cell loss became greater
with increasing gap distance. With the increased gap distance, more RBCs and WBCs attempted to
pass through the space between the ﬁlter gaps while also pushing against the previously captured
U937 cells, resulting in an increase in U937 cell loss and a decrease in the sorting efﬁciency.
However, a further decrease in the gap distance below 8 μm facilitates capturing RBCs and
induced a lower purity of U937 cell separation.
We also tested the U937 cell capture rate of the device under various input ﬂow rate from 0.05
to 1.0 ml/h [Fig. 2(b)]. When the ﬂow rate increased for achieving higher throughput, the percent-
age of captured U937 cells in the matrix was decreased; this means that the high ﬂow rate induces
the undesirable shear stress-induced cell deformation. Under the input ﬂow rate of 0.2 ml/h, the
U937 cell capture rate was about 97%, higher than other ﬂow conditions. The presented approach
for U937 cell sorting has a trade-off between the separation efﬁciency and throughput. If the ﬂow
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rate is increased for achieving higher throughput, the pushing forces imposed on trapped U937
cells accelerate deformation and the cells can be released into the ﬂuid stream from the matrix
without capturing. The higher number of released U937 cells under the high pressure also affects
the U937 cell recovery rate. Thus, we chose to use 2% hematocrit under 0.2 ml/h input ﬂow rate
for optimizing both the throughput and the separation performance.
Validation of sheathless cell focusing and dielectrophoretic live cell separation
The focusing capability of the device with U937 cells was ﬁrst tested under the input ﬂow rate
of 0.2 ml/h. We determined focusing variation for all experiments by measuring the positions of
individual particles in the observation region (562 μm in width). All U937 cells were successfully
focused on the side wall after 243 obstacles, achieving two narrow focusing streams [Fig. 3(a)]. At
such circumstances, they were driven to either the right and left sidewalls by the obstacles. The
focusing positions were 9.94 ± 3.68 and 549.14 ± 8.37 μm for U937 cells. We also investigated the
lateral positions of U937 cells passed through the microchannel without obstacles, and their lateral
positions were 287.24 ± 140.50 μm [Fig. 3(b)]. The input ﬂow rate affects the cell focusing efﬁ-
ciency. If we increase the ﬂow rate higher than 0.6 ml/h, U937 cells could not keep their focusing
widths because of the inertial effects.
At certain high concentration, particle–particle interaction and nonspeciﬁc agglomeration of
cells and particles tend to inﬂuence the separation resolution and purity by deforming the pressure
ﬁelds and colliding with each other. Thus, a microﬂuidic separation typically requires multiple
rounds of separation to reduce the exact operational limit of particle concentration and particle–par-
ticle interaction phenomena. However, our microﬂuidic platform achieved U937 cell separation
purity of >85% in a single round of separation, which is the reason why the smaller blood cells
were separated completely at the microﬁlter F2 and the reduced cell volume did not disrupt the
focusing proﬁle.
After studying the particle trajectories of U937 cells in the integrated separation microﬂuidic
device, the DEP separation was investigated and the results are shown in Fig. 3. The cells were
introduced into the DEP separation zone with a ﬂow rate of 0.2 ml/h. When the electric ﬁeld was
off, both live and dead U937 cells ﬂowed straightly through the microchannel without any lateral
displacement and exited the side channel via the inlet I1 due to the hydrodynamic ﬂow [Fig. 3(c)].
When the electric ﬁeld was applied with an AC ﬁeld of 15 V peak-to-peak at a frequency of
0.5 MHz, most of the pre-focused viable U937 cells (in green) exerting strong positive DEP force
were deﬂected laterally toward the center of chevron-shaped DEP electrodes, whereas most of the
dead U937 cells (in red) remained a straight trajectory due to weaker DEP force and exited the side
FIG. 2. Separation efﬁciency of cancer cells from diluted blood. (a) Plot of U937 cell recovery rate according to a gap dis-
tance of hydrodynamic ﬁlter (F2) array from 8 to 11 μm under the input ﬂow rate of 0.2 ml/h. (b) Plot of U937 cell recovery
rate according to input ﬂow rate with 8-μm-gap hydrodynamic ﬁlter array.
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channel via the inlet I1. The deﬂected viable U937 cells were then transferred to the single-cell
trapping zone near outlet O2.
To optimize the sorting efﬁciency, the voltage- and ﬂow rate-dependent DEP cell deﬂection
was also investigated [Fig. 3(c)]. The applied ﬂow rate was ﬁxed as 0.2 ml/h and the applied
voltage was adjusted from 8 to 20 Vpp at a frequency of 0.5 MHz. After entering the DEP sorting
region, U937 cells were deﬂected from the left and right sidewalls to the center of DEP electrodes.
At the voltage of 20 Vpp, most of the live U937 cells could be focused toward the center; however,
the cells were unable to successfully deﬂect at relatively low voltages of 8 and 12 Vpp. The lateral
positions of dead U937 cells were 12.12 ± 3.61 and 552.31 ± 8.54 μm at 20 Vpp. The lateral
positions of live U937 cells were 9.85 ± 3.79 and 550.11 ± 7.86 μm at 8 Vpp, 73.71 ± 43.52 μm
and 494.96 ± 34.70 μm at 12 Vpp, 294.40 ± 121.45 μm at 16 Vpp, and 284.37 ± 38.79 μm at 20 Vpp.
We avoided the high voltages above 20 Vpp to maximize the viability of U937 cells. As
increasing ﬂow rate will reduce the cell sorting time and increase the throughput, we tested the
DEP deﬂection of live U937 cells under various input ﬂow rates ranging from 0.1 to 0.4 ml/h.
FIG. 3. Dielectrophoretic live cell sorting of hydrodynamically separated cancer cells. (a) Fluorescence streak images of
U937 cells in the grooved microchannel. The cells are successfully guided by locally patterned slanted grooves and focusing
efﬁciency is improved with increasing number of obstacles. Input ﬂow rate is 0.2 ml/h. (b) Cell measurement according to
the existence of obstacle array was performed at the end of focusing zone (width of 562 μm) under the input ﬂow rate of 0.2 ml/h
and plotted in the focusing histograms. Each focusing histogram was obtained from the measurement of more than 180 cells.
(c) Continuous sorting of dead and live U937 cells under the different voltage (8 to 20 Vpp) and ﬂow rate conditions (0.1 to
0.4 ml/h). Each focusing histogram was obtained from the measurement of more than 180 cells. The channel wall is outlined
with dotted lines for clarity. Scale bars, 200 μm.
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If the ﬂow rate is increased to 0.4 ml/h for achieving higher throughput, the number of introduced
U937 cells was increased; however, the percentage of deﬂected single U937 cells was dramati-
cally decreased. This means that the high ﬂow rate causes undesirable passing through the DEP
sorting region due to higher hydrodynamic force. The non-deﬂected live cell would be trans-
ported to outlet O1 and induce low cell purity. Under a total ﬂow rate of 0.2 ml/h, the percentage
of deﬂected single U937 cells was about 98%, higher than other ﬂow conditions. Also, the
deﬂected cells were trapped around the electrode instead of ﬂowing through the microchannel
under the application of above 20 Vpp. This results in a trade-off between the DEP sorting efﬁ-
ciency and throughput. In addition, at higher ﬂow rates, the hydrodynamic pressure imposed on
single U937 cells trapped in downstream trapping arrays (near outlet O2) accelerates deformation
and the trapped single cells can be released into the ﬂuid stream from the single-cell trap without
capturing.
On-chip trapping of U937 cells and viability assay
As a proof-of-concept, we demonstrated the trapping of DEP-sorted U937 cells to investigate
device trapping efﬁciency as well as the feasibility of single-cell monitoring and analysis for
trapped target cells [Fig. 4(a)]. The high-throughput microﬂuidic trapping array contains highly
packed 400 single-cell traps, designed with small dimensions to ﬁt within a microscopic ﬁeld of
view and can be ﬁlled within 3 min, enabling the observation and identiﬁcation of every single
U937 cell ﬂowing through the channel [Figs. 4(b) and 4(c)]. We designed the dummy traps at each
end of the arrays to make cells experience similar ﬂow rates near each trap. The dummy traps make
cells move closer to the traps after passing the serpentine channel. Therefore, cells were mainly
trapped in the middle of each row of the arrays instead of in the dummy traps.24 The trapping efﬁ-
ciency of DEP-sorted U937 cells within the downstream single-cell array (near outlet O2) was also
quantiﬁed. The percentage of captured U937 cells within the 400 single-cell trapping arrays under
the voltage application of 8, 16, and 20 Vpp were 0.60 ± 0.28%, 73.65 ± 2.13%, and 82.9 ± 1.97%,
respectively [Fig. 4(d)].
FIG. 4. Single-cell entrapment of DEP separated live U937 cells. (a) Fluorescent micrograph of high-density 400 single-cell
trapping arrays. (b) Bright-ﬁeld and (c) ﬂuorescent image of stained live U937 cells separated by dielectrophoretic force.
Scale bars, 100 μm.
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Isolation of single monocytes from blood
Figure 5(a) shows the continuous separation of single monocytes at the chevron-shaped DEP
electrodes. After 25 s positive DEP exposure, the single monocytes were successfully deﬂected
toward the center of chevron-shaped electrodes. The deﬂection of monocytes allows the single-cell
isolation at the downstream microwell arrays after turning off the voltage. A cell viability assay
was performed to see if the monocytes are actually live in the microwell array [Fig. 5(c)]. After
single-cell isolation, we introduced the Calcein AM staining solution to stain the single monocytes
for 15 min. We also quantiﬁed monocyte viability in microwell arrays under the different voltage
applications. The viabilities of monocytes separated under 12, 16, and 20 Vpp were 89.8%, 87.6%,
and 84.8%, respectively. Despite the exposure of electric ﬁeld under the positive DEP regime, the
percentage viabilities of monocytes were stable at ∼84%. This was because PBS was exchanged
for DEP buffer at the microwell array after DEP separation, resulting in the maintenance of cell via-
bility within the microwell arrays. The viability of cells within the microwell arrays could be
further improved by enlargement of channel height over 100 μm, which allow on-chip cell culture.
The single-cell capturing efﬁciency was also quantiﬁed according to the different voltage applica-
tions. The capturing efﬁciencies of monocytes separated under the 12, 16, and 20 Vpp were 56.6%,
74.0%, and 83.2%, respectively. The lower voltage interrupts the isolation of single monocytes
because of the lower number of deﬂected cells by the pDEP force. As the number of monocytes is
very low in the diluted blood, the appropriate higher voltage would be necessary to isolate single
monocytes in the microﬂuidic device.
FIG. 5. Single-cell entrapment of DEP separated live U937 cells. (a) DEP separation of live monocytes from diluted blood.
(b) Bright-ﬁeld image of isolated single monocytes separated by DEP force under the application of 20 Vpp and 0.5MHz.
(c) Percentage of live monocytes and single-monocyte capturing efﬁciency after the DEP separation and isolation. Scale
bars, 100 μm.
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DISCUSSION
The applicability of this size-selective single-cell trapping platform for monocyte isolation was
demonstrated by integrating different microﬂuidic components: the hydrodynamic separation ﬁlter,
the DEP electrodes, and the single-cell trapping. The presented system enables single-cell analysis
with a large degree of ﬂexibility, which are envisioned to open up a variety of attractive applica-
tions, such as (i) increased separation and isolation throughput of the single monocytes by integrat-
ing multiple replicates of microﬂuidic devices; (ii) maintenance of the viability of isolated cells for
further analysis; and (iii) the simplicity of single-cell trapping design which enables the integration
of active microﬂuidic components. However, we encountered a challenge during the cell separation
that the current platform can only process up to 2% diluted blood. As the hematocrit increases, the
separation performance decreases due to the unwanted clogging of RBCs around the ﬁlter due to
their cell-to-cell interaction. The device can deal with a higher hematocrit level sample if the
device is massively parallelized. We determined that the presented device could be arrayed with 10
arranged channels in parallel with a single inlet and 12 outlets integrated into the 3-in. PDMS
device that can deal with large volumes of blood samples. We simply calculated that when 2%
diluted blood is tested at 0.2 ml/h, 10 000 single monocytes can be isolated in 5 min. The simple
and highly scalable channel design facilitates the single-cell isolation throughput to be greatly
enhanced by stacking multiple sorting layers without compromising performance parameters such
as purity and recovery.
To enhance user-friendliness, microﬂuidic chips with standard interconnecting inlet ports
could prove beneﬁcial. For example, if the microﬂuidic devices were designed to be compatible
with pipettes such that the inlets are directly connected to a pipette tip, constant ﬂow rates can be
generated manually with back-and-forth movement. This would eliminate the need for complex
ﬂuid interconnections and bulky precision pumps. The combination of the pipette and the proposed
microﬂuidic chip offers the following advantages: (i) stable monocyte separation and isolation with
the simple, manual operation of a pipette; (ii) continuous monocyte separation without clogging;
and (iii) applicable for a wider community of end-users to be familiar with its use so that non-
experts can easily carry out the procedures. On the other end of the spectrum, this platform could
be adapted to be compatible with automated liquid dispensing systems for high throughput sample
processing.
The presented platform offered the capability to investigate the cellular heterogeneity of
normal monocytes after the continuous separation under the DEP regime. One of the main chal-
lenges in the proposed platform is that the monocytes can be manipulated only under positive DEP
operating conditions, in which cells are trapped at constrictions where electric ﬁeld maxima may
be causing cell attachment to the electrodes. This could lead to the cell damage and deteriorates the
separation performance.
While in our proof-of-concept demonstration, we showed high-throughput, size-selective
isolation of single U937 cell spiked in blood, the proposed method would be amenable to other
applications in which single-cell screening is required. The large-scale microwell arrays can be
adapted to high-throughput single-cell analyzers,33 label-free detection via ﬂuorescence lifetime
imaging,34 and lensless observation,35 which enable analyzing a large population of cells with
high statistical precision in a practical period of time. Such applications include imaging and
detection of single cells of interest in stem-cell biology, medicine, pharmaceutics, and environ-
mental science.
CONCLUSION
In this paper, we presented a continuous ﬂow, integrated microﬂuidic device to isolate single
monocytes from the diluted blood in microﬂuidic arrays in a size-selective manner. The hydrody-
namic ﬁltration enables the separation of U937 cells from the diluted blood based on their different
sizes. The device also includes the utilization of DEP force in an array of oblique interdigitated
electrodes and the AC ﬁeld control to realize continuous separation of viable monocytes.
Signiﬁcant technical ﬁndings are summarized as follows:
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(1) It was found that two different-sized microﬁlters allow for separation and recovery of
medium-sized monocytes from the diluted blood cell suspension with heterogeneous size dis-
tribution. Extensive experiments demonstrated the notable separation of monocytes and
blood cells in terms of various ﬂow conditions and hematocrits. The application of back-ﬂow
by switching the ﬂow direction allows the transfer of only monocytes to the DEP electrodes,
while the ﬁltered blood cells are removed from the outlet reservoirs.
(2) The separation efﬁciency and purity for normal U937 cells were quantiﬁed, exhibiting consis-
tent performance when the ﬂow rate is ﬁxed as 0.2 ml/h. Separation efﬁciency up to 96.4%
can be obtained for normal U937 cells at the center outlet connected to the microwell arrays,
with purity up to 84%.
(3) The separated normal U937 cells were successfully isolated individually in the 400-microwell
arrays downstream. Up to 98% single-cell occupancy of the entire traps was achieved, with
average single-cell occupancy of 94 ± 4%. With a U937 cell concentration of 1 × 106 cells
per ml, and a ﬂow rate of 0.2 ml/h, 400 U937 cells were trapped sequentially and determinis-
tically within 40 s.
The presented size-selective, label-free, and non-destructive microﬂuidic single-cell analysis plat-
form with the DEP sorting of monocytes would have a myriad of applications in single-cell
genetic analysis, stem cell biology, point-of-care diagnostics, and cancer diagnostics.
SUPPLEMENTARY MATERIAL
See supplementary material for the overall microchannel design and the COMSOL electro-
static simulation of the electric ﬁeld on the surface of the electrodes.
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